ImmunoPrecise Antibodies Ltd.
IPA
$3.20
$0.5721.67%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.72M | 8.92M | 2.54M | 2.83M | 2.52M |
| Total Receivables | 3.48M | 3.36M | 3.81M | 2.55M | 3.26M |
| Inventory | 1.52M | 1.33M | 1.44M | 1.35M | 1.56M |
| Prepaid Expenses | 859.70K | 720.00K | 1.19M | 1.25M | 1.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.57M | 14.33M | 8.97M | 7.98M | 8.36M |
|
|
|||||
| Total Current Assets | 13.57M | 14.33M | 8.97M | 7.98M | 8.36M |
| Net Property, Plant & Equipment | 11.41M | 10.52M | 11.45M | 11.90M | 12.15M |
| Long-term Investments | 5.96M | 5.44M | 5.68M | 5.68M | 5.59M |
| Goodwill | 5.96M | 5.44M | 5.68M | 5.68M | 5.59M |
| Total Other Intangibles | 772.20K | 776.60K | 16.51M | 16.96M | 17.14M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 454.50K | 399.40K | 414.10K | 414.10K | 408.20K |
| Total Assets | 32.16M | 31.46M | 43.03M | 42.93M | 43.65M |
|
|
|||||
| Total Accounts Payable | 3.82M | 1.72M | 2.57M | 3.27M | 2.96M |
| Total Accrued Expenses | 343.80K | 1.31M | 1.29M | 217.20K | 620.60K |
| Short-term Debt | -- | -- | 2.22M | 1.88M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.34M | 1.17M | 1.19M | 1.16M | 1.14M |
| Total Finance Division Other Current Liabilities | 1.02M | 1.97M | 1.63M | 1.56M | 1.19M |
| Total Other Current Liabilities | 1.02M | 1.97M | 1.63M | 1.56M | 1.19M |
| Total Current Liabilities | 6.52M | 6.17M | 8.90M | 8.09M | 5.91M |
|
|
|||||
| Total Current Liabilities | 6.52M | 6.17M | 8.90M | 8.09M | 5.91M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 2.22M | 1.88M | -- |
| Capital Leases | 8.36M | 7.77M | 8.37M | 8.61M | 8.82M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 180.90K | 164.40K | 2.30M | 2.44M | 2.96M |
| Total Liabilities | 15.06M | 14.10M | 19.58M | 19.14M | 17.69M |
|
|
|||||
| Common Stock & APIC | 107.98M | 103.04M | 96.89M | 96.15M | 96.16M |
| Retained Earnings | -93.21M | -87.50M | -75.43M | -74.25M | -71.71M |
| Treasury Stock & Other | 2.33M | 1.81M | 1.99M | 1.88M | 1.51M |
| Total Common Equity | 17.10M | 17.36M | 23.45M | 23.78M | 25.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.10M | 17.36M | 23.45M | 23.78M | 25.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.10M | 17.36M | 23.45M | 23.78M | 25.96M |
|
|
|||||